Sierra Oncology commits to sharing clinical study data with qualified researchers to enable enhancement of public health.
Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib / Mesa, Ruben; Verstovsek, Srdan; Platzbecker, Uwe; Gupta, Vikas; Lavie, David; Giraldo, Pilar; Recher, Christian; Kiladjian, Jean-Jacques; Oh, Stephen T; Gerds, Aaron T; Devos, Timothy; Passamonti, Francesco; Vannucchi, Alessandro M; Egyed, Miklos; Lech-Maranda, Ewa; Pluta, Andrzej; Nilsson, Lars; Shimoda, Kazuya; McLornan, Donal; Kawashima, Jun; Klencke, Barbara; Huang, Mei; Strouse, Bryan; Harrison, Claire. - In: HAEMATOLOGICA. - ISSN 1592-8721. - ELETTRONICO. - (2023), pp. 0-0. [10.3324/haematol.2023.283106]
Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinib
Vannucchi, Alessandro M;Huang, Mei;
2023
Abstract
Sierra Oncology commits to sharing clinical study data with qualified researchers to enable enhancement of public health.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Clinical outcomes of patients with myelofibrosis.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
2.63 MB
Formato
Adobe PDF
|
2.63 MB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
